Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Kasuga, A.
space
  arrow  Saruta, T.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Insulin-Dependent Diabetes Mellitus Associated with Parvovirus B19 Infection

right arrow Akira Kasuga, MD; Reiko Harada, MD; and Takao Saruta, MD

15 October 1996 | Volume 125 Issue 8 | Pages 700-701


TO THE EDITOR:

Viruses may play a role in the pathogenesis of insulin-dependent diabetes mellitus (IDDM) [1]. Coxsackievirus P2-C shares homologous sequences with glutamic acid decarboxylase, an autoantigen for IDDM; it has been suggested that this mimicry may trigger autoimmunity. We report a case of IDDM associated with infection with parvovirus B19, which shares homologous sequences with IA-2, another autoantigen for IDDM.

A 21-year-old man developed IDDM after experiencing flu-like symptoms. He subsequently developed a lacy, reticular, erythematous rash that worsened with changes in environmental temperature. These findings are typical of erythema infectiosum. Laboratory findings showed abrupt onset of IDDM, with a plasma glucose level of 313 mg/dL, a hemoglobin A1c value of 8.8%, and a glucagon-stimulated C-peptide level of 1.0 ng/mL.

At admission, IgM antibody against parvovirus B19 and viral DNA was detected; this antibody was no longer detectable after 1 month, at which time IgG antibody appeared. Both the admission and follow-up samples were strongly positive (85th percentile among IDDM sera) for IA-2 antibody, which had been titrated by a radioligand binding assay, and weakly positive (35th percentile) for glutamic acid decarboxylase. In addition, extracellular domains of IA-2 had some amino acid sequences (for example,82 LQGVLRQLMSQGLSWH98 [2]) that mimicked parvovirus B19 (LQGFMTLGIANWLSWE [3]) but glutamic acid decarboxylase did not.

The IA-2 antigen contains approximately 570 amino-acid extracellular domains, whereas glutamic acid decarboxylase is distributed in intracellular vesicles. We speculate that parvovirus B19 infection might prime T-cell clones for the mimicry site, induce autoimmunity against the extracellular domain of IA-2, and ultimately damage the ß-cells.

A large-scale study should be done to further clarify the relation between the pathogenesis of IDDM and parvovirus B19 infection.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Tokyo Denryoku Hospital, Tokyo, Japan
Keio University School of Medicine, Tokyo, Japan


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Eisenbarth GS, Ziegler AG, Colman PA. Pathogenesis of insulin-dependent diabetes mellitus. In: Kahn CR, Weir GC, eds. Joslin's Diabetes Mellitus. Malvern, PA: Lea & Febiger; 1994:216-39.

2. Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biology. 1994; 13:505-14.

3. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol. 1985; 58:921-36.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.




This article has been cited by other articles:


Home page
JBJSHome page
F. Teboul, P. Bizot, R. Kakkar, and L. Sedel
Surgical Management of Trapezius Palsy
J. Bone Joint Surg. Am., September 1, 2004; 86(9): 1884 - 1890.
[Abstract] [Full Text] [PDF]


box Article
 arrow  Table of Contents                
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Kasuga, A.
space
  arrow  Saruta, T.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online